Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Oral administration of 500 mg rosemary twice daily for one month significantly improved prospective and retrospective memory, reduced anxiety and depression, and improved sleep quality (excluding sleep latency and duration) [PMID:29389474]
Rosemary oil is used to enhance circulation and extend the anagen phase to promote hair growth and scalp health [PMID:40656290]; standardized extracts have been tested for efficacy in testosterone-induced alopecia in rat models [PMID:40632089]
Shows potential in treating Alzheimer's disease, Parkinson's disease, migraine, and cognitive disorders through neuroprotective and anti-apoptotic effects [PMID:35873824, 40055645]
Active constituents like rosmarinic and carnosic acid are explored for managing obesity, insulin resistance, hypertension, and dyslipidemia [PMID:40783038]
Preclinical evidence suggests anticancer potential, particularly in colorectal cancer, through the modulation of signaling pathways and apoptosis [PMID:21955093, 32532056]
Sécurité et effets indésirables
Posologie et administration
Synthèse des preuves
Sources PubMed
- 1.PMID: 30621719 (2019) — Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. · Journal of biomedical science
- 2.PMID: 39096378 (2025) — Toxicity and safety of rosemary (Rosmarinus officinalis): a comprehensive review. · Naunyn-Schmiedeberg's archives of pharmacology
- 3.PMID: 32963731 (2020) — Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. · Iranian journal of basic medical sciences
- 4.PMID: 29389474 (2018) — Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. · Complementary therapies in clinical practice
- 5.PMID: 40055645 (2025) — Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer's disease.